牛血清白蛋白市场－全球产业规模、份额、趋势、机会和预测（按产品、应用、地区和竞争细分，2020-2030 年）

2024 年全球牛血清白蛋白市场价值为 56.2 亿美元，预计在预测期内将呈现强劲成长，到 2030 年的复合年增长率为 8.02%。全球牛血清白蛋白市场是更广泛的生物技术和製药行业中一个充满活力且快速发展的行业。牛血清白蛋白 (BSA) 是一种从牛血清中提取的多功能蛋白质，在各个科学和研究领域有着广泛的应用。该市场涵盖 BSA 的生产、分销和利用，服务于广泛的最终用户，包括学术和研究机构、製药公司、生物技术公司和诊断实验室。例如，根据美国国家医学图书馆的数据，2022 年全球共进行了 3.1 亿次大型手术。其中，约有 4,000 万至 5,000 万次在美国进行，而约有 2,000 万次在欧洲进行。这凸显了全球对外科手术的巨大需求，其中美国和欧洲占了总量的很大一部分。

推动全球牛血清白蛋白市场成长的关键因素包括其在细胞培养和各种生化测定中的重要作用、其在各种诊断和治疗产品中作为稳定剂的用途、以及其在製药和生物技术领域日益增长的需求。 BSA是细胞培养基中的关键成分，提供必需的营养物质、生长因子和缓衝能力，从而促进细胞生长和蛋白质生产，使其成为生物加工中不可或缺的物质。

关键市场驱动因素

不断发展的生物製药产业

主要市场挑战

伦理问题和替代来源

主要市场趋势

细胞培养应用的扩展

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：全球牛血清白蛋白市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产物（人血清白蛋白、牛血清白蛋白、重组血清白蛋白）
  • 依应用（治疗、药物传输、培养基、疫苗成分、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按产品
  • 按应用
  • 按地区

第五章：亚太地区牛血清白蛋白市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品
  • 按应用
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第六章：欧洲牛血清白蛋白市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 西班牙
  • 义大利
  • 英国

第七章：北美牛血清白蛋白市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 墨西哥
  • 加拿大

第八章：南美牛血清白蛋白市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第九章：中东和非洲牛血清白蛋白市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第十章：市场动态

• 驱动程式
• 挑战

第 11 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 12 章：全球牛血清白蛋白市场：SWOT 分析

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Thermo Fisher Scientific
• Bio-Rad Laboratories, Inc (US)
• Merck KGAA (Germany)
• Itoham Yonekyu Holdings Inc (Japan)
• Proliant Biologicals (US)
• Kraeber & Co Gmbh (Germany)
• Rockland Immunochemicals Inc (US)
• Rocky mountain biologicals (US)
• BelHealth investment partners, LLC (US)
• Bio-Techne Corporation (US)

第十五章：战略建议

第16章调查会社について・免责事项

Global Bovine Serum Albumin Market was valued at USD 5.62 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 8.02% through 2030. The global bovine serum albumin market is a dynamic and rapidly evolving sector within the broader biotechnology and pharmaceutical industry. Bovine serum albumin (BSA) is a versatile protein derived from cow's blood serum and has found extensive applications across various scientific and research fields. This market encompasses the production, distribution, and utilization of BSA, serving a wide range of end-users, including academic and research institutions, pharmaceutical companies, biotechnology firms, and diagnostic laboratories. For instance, according to the National Library of Medicine, a total of 310 million major surgeries were conducted worldwide in 2022. Of these, approximately 40-50 million took place in the U.S., while around 20 million were performed across Europe. This highlights the significant global demand for surgical procedures, with the U.S. and Europe comprising a substantial portion of the total volume.

Key factors driving the global bovine serum albumin market's growth include its vital role in cell culture and various biochemical assays, its use as a stabilizer in a variety of diagnostic and therapeutic products, and its increasing demand in the pharmaceutical and biotechnology sectors. BSA serves as a critical component in cell culture media, providing essential nutrients, growth factors, and buffering capacity, thereby facilitating cell growth and protein production, making it indispensable in bioprocessing.

Key Market Drivers

Growing Biopharmaceutical Industry

The rapid expansion of the biopharmaceutical industry has significantly contributed to the growth of the global bovine serum albumin (BSA) market. This burgeoning sector, driven by the development of biologics such as monoclonal antibodies, vaccines, and gene therapies, heavily relies on BSA for its unique properties and functionalities. BSA serves as a stabilizing agent during the production of biopharmaceuticals, which are complex and fragile molecules. Its ability to protect these sensitive molecules from denaturation and aggregation is crucial for ensuring the safety and efficacy of the final drug products.

The biopharmaceutical industry's increasing demand for BSA is rooted in several factors. First, the biologics market has experienced remarkable growth due to the effectiveness of these therapies in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. As more biologics enter the market and new therapies are developed, the demand for BSA as a stabilizing and protecting agent in their production processes rises correspondingly.

Key Market Challenges

Ethical Concerns and Alternative Sources

One of the primary challenges facing the BSA market is the growing ethical concern surrounding the use of bovine-derived products. The extraction of BSA from cow's blood serum is associated with ethical dilemmas, as it raises questions about the welfare of animals involved in the process. Cows may undergo invasive procedures to collect serum, raising concerns about cruelty and the treatment of these animals. In response to these concerns, consumers, organizations, and researchers are advocating for more ethical practices in the production of BSA and seeking alternatives that do not involve animal exploitation. For instance, according to a July 2022 report from the Centers for Disease Control and Prevention, six in ten Americans have at least one chronic condition, including stroke, heart disease, cancer, or diabetes. The increasing prevalence of chronic illnesses and the growing demand for personalized medicine are anticipated to drive the demand for bovine serum albumin in the region.

The ethical concerns surrounding bovine-derived BSA have driven the exploration of alternative sources of albumin. Several promising alternatives have emerged, each aiming to address ethical, sustainability, and safety issues. Two notable alternatives are recombinant albumin and plant-based albumin.

Key Market Trends

Expansion of Cell Culture Applications

The expansion of cell culture applications is a key driver boosting the global bovine serum albumin (BSA) market. Cell culture techniques have gained widespread adoption in academic research, biotechnology, and the pharmaceutical industry. BSA, derived from cow's blood serum, is an indispensable component in cell culture media, providing essential nutrients, growth factors, and buffering capacity that are critical for cell growth and protein production.

Researchers and manufacturers are increasingly relying on cell culture to propagate cells for various applications, such as drug development, vaccine production, and regenerative medicine. The ability to create a controlled environment that supports cell growth and replication is essential for the development of advanced therapies and bioprocessing. BSA plays a pivotal role in these processes, ensuring the optimal conditions for cell growth, enhancing productivity, and improving the reproducibility of experiments.

Key Market Players

• Thermo Fisher Scientific
• Bio-Rad Laboratories, Inc (U.S.)
• Merck KGAA (Germany)
• Itoham Yonekyu Holdings Inc (Japan)
• Proliant Biologicals (U.S.)
• Kraeber & Co Gmbh (Germany)
• Rockland Immunochemicals Inc (U.S.)
• Rocky mountain biologicals (U.S.)
• BelHealth investment partners, LLC (U.S.)
• Bio-Techne Corporation (U.S.)

Report Scope:

In this report, the Global Bovine Serum Albumin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bovine Serum Albumin Market, By Product:

• Human Serum Albumin
• Bovine Albumin
• Recombinant Serum Albumin

Bovine Serum Albumin Market, By Application:

• Therapeutic
• Drug Delivery
• Culture Media
• Vaccine Ingredient
• Others

Bovine Serum Albumin Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bovine Serum Albumin Market.

Available Customizations:

Global Bovine Serum Albumin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Bovine Serum Albumin Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product (Human Serum Albumin, Bovine Albumin, Recombinant Serum Albumin)
  • 4.2.2. By Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient, Others)
  • 4.2.3. By Region
  • 4.2.4. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. By Region

5. Asia Pacific Bovine Serum Albumin Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By Application
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Bovine Serum Albumin Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product
      • 5.3.1.2.2. By Application
  • 5.3.2. India Bovine Serum Albumin Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product
      • 5.3.2.2.2. By Application
  • 5.3.3. Australia Bovine Serum Albumin Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product
      • 5.3.3.2.2. By Application
  • 5.3.4. Japan Bovine Serum Albumin Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product
      • 5.3.4.2.2. By Application
  • 5.3.5. South Korea Bovine Serum Albumin Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product
      • 5.3.5.2.2. By Application

6. Europe Bovine Serum Albumin Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Bovine Serum Albumin Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Germany Bovine Serum Albumin Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Spain Bovine Serum Albumin Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
  • 6.3.4. Italy Bovine Serum Albumin Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By Application
  • 6.3.5. United Kingdom Bovine Serum Albumin Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By Application

7. North America Bovine Serum Albumin Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Bovine Serum Albumin Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. Mexico Bovine Serum Albumin Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. Canada Bovine Serum Albumin Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application

8. South America Bovine Serum Albumin Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Bovine Serum Albumin Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. Argentina Bovine Serum Albumin Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Colombia Bovine Serum Albumin Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application

9. Middle East and Africa Bovine Serum Albumin Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Bovine Serum Albumin Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Saudi Arabia Bovine Serum Albumin Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. UAE Bovine Serum Albumin Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Bovine Serum Albumin Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Products
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Bio-Rad Laboratories, Inc (U.S.)
• 14.3. Merck KGAA (Germany)
• 14.4. Itoham Yonekyu Holdings Inc (Japan)
• 14.5. Proliant Biologicals (U.S.)
• 14.6. Kraeber & Co Gmbh (Germany)
• 14.7. Rockland Immunochemicals Inc (U.S.)
• 14.8. Rocky mountain biologicals (U.S.)
• 14.9. BelHealth investment partners, LLC (U.S.)
• 14.10. Bio-Techne Corporation (U.S.)

15.Startegic Recommendation

16.About Us & Disclaimer